Nelesh Govender (also @neleshg.bsky.social)
@neleshg
Followers
2K
Following
4K
Media
208
Statuses
2K
I study fungal diseases. Prof @witshealthfac. NIHR Research Prof. Hon Prof @MRCcmm @StGeorgesUni @UCTHealthSci. Sabbatical @nicd_sa. MD, micro, epi 🌈
Joined May 2009
"Instead of clustering with more recent outbreaks, a pathogen assumed to evolve steadily appears, in part, unchanged for half a century." New letter—Ebola virus in Kasai revives 50-year-old questions on viral latency
0
4
15
💬 Want to talk about #HIV in a way that uplifts and respects everyone? 📲 Visit https://t.co/lCeMjLv4Vz for examples of empowering language to use! #HIVLanguageMatters #WordsMatter
0
6
22
UPDATE: Ebola in the Democratic Republic of Congo. We rapidly mobilised a team in Bulape health zone to respond to the outbreak alongside the Congolese health authorities and @WHO. A treatment centre began admitting patients yesterday. More details:
msf.org
MSF is responding to this latest Ebola outbreak in the Democratic Republic of Congo, along with the WHO and Ministry of Health.
1
17
31
📢🌍We’re delighted to announce that we will be offering a travel grant of up to £550 to support the attendance of an #LMICdelegate! 🌍📢 Simply submit an abstract for oral presentation, and if accepted, you could be awarded the grant! 🔗 https://t.co/1pSeBPL5Lu
#Mycology2026
0
6
8
It’s a full moon today! 🌕 Skywatchers in most of Africa, Europe, Asia and Australia may also see a lunar eclipse, or Blood Moon. Totality will begin around 1730 UTC and last for about 82 minutes. No matter where you are, you can learn how eclipses work: https://t.co/qt42ek6ojZ
784
9K
29K
🆕🔥 Review article @TheLancetInfDis Towards shorter therapy for candidaemia: defining uncomplicated candidaemia in adults #IDXposts
https://t.co/GHXWzMVSdB
1
92
209
#Crypto Meningitis is the most common cause of adult meningitis in Africa. We assessed if lower dose flucytosine at 60 mg/kg was equally effective. Unfortunately while survival was similar, increased rehospitalizations, worse CSF clearance. #IDTwitter
https://t.co/J52P9G0T6A
2
19
47
We've identified 3 Histoplasma lineages in Africa: 1. 'Africa' aligns w/ H. duboisii 2. Hcf matches H. farciminosum 3. 1 African isolate resembles a S American mz5-lineage https://t.co/8JMciBkuyK Part of Rutendo Mapendo's @WitsHealthFac PhD
0
3
10
Global Trends in CD4 Count Measurement and Distribution at First Antiretroviral Treatment Initiation https://t.co/0JnhnTpSQG
academic.oup.com
Despite its critical role in patient care and program evaluation, measurement of CD4 cell count at treatment start has declined to low levels, especially i
0
12
18
This article provides an overview of the current state of handling continuous variables in healthcare research. It discusses the potential limitations of assuming a linear relationship between independent and dependent variables https://t.co/i7i8xOcEg4
bmj.com
Proper handling of continuous variables is crucial in healthcare research, for example, within regression modelling for descriptive, explanatory, or predictive purposes. However, inadequate methods...
1
35
58
MUST READ | South Africa is staging a sequel to Mbeki-era denialism, only this time, the science, solutions, and costs are clearer, argues Professor @FrancoisVenter3. https://t.co/yx4SjnLFJC
spotlightnsp.co.za
South Africa is staging a sequel to Mbeki-era denialism, only this time, the science, solutions, and costs are clearer, argues Professor Francois Venter.
0
9
11
Results from our @NIH CAST-NET cohort study published. Excellent national coverage of cryptococcal antigen screening 🇿🇦 but real challenges to act on CrAg+ results to exclude meningitis and dispense pre-emptive antifungals https://t.co/zgFnWU0i47
0
5
13
During 2016–2023, among 21,195 US patients who tested positive for Candida auris skin colonisation, 6.9% were subsequently found to have a positive clinical specimen, 2.8% from blood Probably an underestimate but useful to know https://t.co/B22CMSMyGI
1
1
4
WHO celebrates this step to really get on track to end AIDS by 2030!Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low- and Middle-Income Countries - News Releases - The Global Fund to Fight AIDS, Tuberculosis and Malaria
theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) today announced it has signed an access agreement with Gilead Sciences to procure lenacapavir, a long-acting injectable for...
0
10
15
We are hiring! Clinical Scientist - Research Professor Closing date: 14 July 2025 https://t.co/vmumoqU48M
0
7
6
Congrats to Serisha Naicker & our 🌍CryptoADAPT team @WitsUniversity, UP, SUN, Imperial, CISM, UZ, Duke for the new @wellcometrust grant Excited to dig into the environmental diversity of Cryptococcus in Africa https://t.co/6eUNYx3GAO
1
0
6
🔥🗞️Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study. Groundbreaking work on a very promising new antifungal. Free access here: https://t.co/rh58X00hvP
0
20
31
Perspective by George R. Thompson III, MD (@GRThompsonMD), and Angel N. Desai, MD, MPH: Addressing Antifungal Drug Resistance — A “One Health–One World” Challenge https://t.co/XR7HfnF0nh
#GlobalHealth
1
3
21
The burden of Neonatal Invasive Candidiasis in Low- and Middle-Income Countries: a systematic review and meta-analysis. ✅ Just Accepted 🔗 https://t.co/NfGNAyZRKf
0
2
6